Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriem Boufraqech

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Scientific Reports|March 9, 2022
Histone H2AX promotes metastatic progression by preserving glycolysis via hexokinase-2Yue Liu, Haojian Li, Crystal N Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2016
Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human CancersMyriem Boufraqech, Lisa Zhang, Naris Nilubol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2017
Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and MetastasesShweta Kotian, Lisa Zhang, Myriem Boufraqech, et al.
World Journal of Surgery|September 2, 2015
FDG PET/CT Scan and Functional Adrenal Tumors: A Pilot Study for LateralizationDhaval Patel, Sudheer Kumar Gara, Ryan J Ellis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2016
Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical CarcinomaKei Satoh, Lisa Zhang, Yaqin Zhang, et al.
Oncotarget|May 7, 2015
Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasisSamira M Sadowski, Myriem Boufraqech, Lisa Zhang, et al.
Surgery|November 19, 2013
MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumorsDhaval Patel, Myriem Boufraqech, Meenu Jain, et al.
Annals of Surgical Oncology|May 17, 2014
Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinomaDhaval Patel, Ryan Ellis, Brandi Howard, et al.
Endocrine-Related Cancer|May 1, 2014
miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3Myriem Boufraqech, Lisa Zhang, Meenu Jain, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 8, 2026
Dual targeting of BRAF<sup>V600E</sup> and ferroptosis results in synergistic anticancer activity via iron overload and enhanced oxidative stressJiangnan Hu, Chandrayee Ghosh, Tejinder P Khaket, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Scientific Reports|March 9, 2022
Histone H2AX promotes metastatic progression by preserving glycolysis via hexokinase-2Yue Liu, Haojian Li, Crystal N Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2016
Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human CancersMyriem Boufraqech, Lisa Zhang, Naris Nilubol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2017
Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and MetastasesShweta Kotian, Lisa Zhang, Myriem Boufraqech, et al.
World Journal of Surgery|September 2, 2015
FDG PET/CT Scan and Functional Adrenal Tumors: A Pilot Study for LateralizationDhaval Patel, Sudheer Kumar Gara, Ryan J Ellis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2016
Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical CarcinomaKei Satoh, Lisa Zhang, Yaqin Zhang, et al.
Oncotarget|May 7, 2015
Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasisSamira M Sadowski, Myriem Boufraqech, Lisa Zhang, et al.
Surgery|November 19, 2013
MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumorsDhaval Patel, Myriem Boufraqech, Meenu Jain, et al.
Annals of Surgical Oncology|May 17, 2014
Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinomaDhaval Patel, Ryan Ellis, Brandi Howard, et al.
Endocrine-Related Cancer|May 1, 2014
miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3Myriem Boufraqech, Lisa Zhang, Meenu Jain, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 8, 2026
Dual targeting of BRAF<sup>V600E</sup> and ferroptosis results in synergistic anticancer activity via iron overload and enhanced oxidative stressJiangnan Hu, Chandrayee Ghosh, Tejinder P Khaket, et al.
Pageof 5